FDA Approved: CABERGOLINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for cabergoline submitted by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Prolactin-secreting Pituitary Adenoma

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)